Prescription drugs, compliments of medicare : The new medicare law is complex and, far from finalizedIn recent months, many asthmatics participating in the Medicare program have focused a great deal of attention on choosing a prescription-drug discount card. However, the more dramatic Medicare ...
Profile: Democrats ask GAO to investigate government-sponsored video on the new Medicare prescription drug lawProfile: Democrats ask GAO to investigate government-sponsored video on the new Medicare prescription drug lawROBERT SIEGEL, MICHELE NORRIS...
The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 created the largest expansion of benefits in the 40-year history of Medicare. It is also the first time in the history of the program that a Medicare benefit will not be available through the basic Medicare progra...
The hard sell: when the new Medicare Prescription Drug Benefit takes effect in January, government will replace the individual consumer as pharma's biggest customer. Onlookers hope that both industry and consumers will come out on top. But first there is the small matter of persuading 30 ...
The Medicare Improvements for Patientsand Providers Act of 2008 (MIPPA)added numerous provisions to MedicarePart D (Table).6 Under the new law, agencies, states,and researchers will be able to usePrescription Drug Event (PDE) data tostudy drug use in Part D, including utilization,safety, eff...
Understanding the incomprehensible: a guide to the new medicare prescription drug benefit for case managers. Understanding the incomprehensible: a guide to the new medicare prescription drug benefit for case managers.Prescription drugNOSMedicare... CL Marshall - 《Lippincotts Case Management Managing the...
When payers (most notably Medicare) look at GLP-1 receptor agonists, they see only the cost. That’s like the FDA reviewing risks while ignoring benefits when considering new medicines. It has to be about value. And when it comes to measuring value, we must embrace a comprehensive view of...
Enacted into law through the 2022 Inflation Reduction Act, all Part D plans (both standalone and Medicare Advantage plans) must offer the opportunity for plan enrollees to opt-in to the program, which will spread their OOP drug payments throughout the year. And while it has the potential to...
C. Baird Brown
14. Allowing CMS to request and collectinformation directly from pharmacy benefitmanagers, pharmacies, and other first-tier,downstream, or related entities that con-tract with Part D sponsors in order "to bet-ter detect fraud" and increase CMS' abilityto collect identified Medicare overpaymentsfrom...